Pharmaceutical Industry Information Portal

Moderna to build a new vaccine plant in the UK

U.S. biotech firm Moderna  will build a new research and manufacturing centre in Britain to develop vaccines against new...

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the...

Italian Stevanato Group expands the boundaries by opening a manufacturing hub in China

The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...

Amgen sells its Turkish manufacturing arm for $135M

Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Sanofi to cut out-of-pocket insulin costs to $35 for U.S. patients

French drugmaker Sanofi  said on Wednesday uninsured diabetes patients in the United States will pay no more than $35...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

New technologies are an integral part of diabetes management

A large population of people living with type 1 diabetes are set to be offered new technology to help...

EMA recommends approval of Spikevax for children aged 6 to 11

EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

GSK comes close to creating a hard-to-reach RSV vaccine

GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim...

Hikma Pharmaceuticals down 30%, stock to buy on fall

Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by...